At a glance
- Originator Aventis
- Class Anti-ischaemics; Vitamins
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial ischaemia
Most Recent Events
- 15 Feb 1995 Discontinued-Preclinical for Myocardial ischaemia in France (Unknown route)